This is a preview of subscription content, log in via an institution to check access.
Literatur
Bergsjö, P.: Progesteron and progestional compounds in the treatment of advanced endometrial carcinom. Acta endocr. (Kbh.)49, 412 (1965).
Budd Wentz, W.: Effect of a progestional agent on endometrial hyperplasia and endometrial cancer. Obstet. and Gynec.24, 370 (1964).
Cekon, F.: Ein Beitrag zur Frage der Disposition, Konstitution, der Korrelationsstörungen und hormonalen Einflüsse in bezug auf das Korpuscarcinom. Wien. Klin. Wschr.7, 113 (1963).
Chance, B., andG. Hollunger: Inhibition of electron and energy transfer in mitochondria. J. biol. Chem.278, 418 (1963).
Chiari, H.: Das histologische Bild des soliden Korpuscarcinoms. In:Seitz-Amreich, Biologie und Pathologie des Weibes, Bd. 4, S. 619. Berlin: Urban & Schwarzenberg 1955.
Crabtree, H. G.: Observations on the carbohydrate metabolism of tumors. Biochem. J.23, 536 (1929).
Dreyfus, M. L.: The metabolism of human endometrium with special reference to adenomyosis and hyperplasia of endometrium. Amer. J. Cancer38, 551 (1940).
Greenstein, J. P.: The oxydative response of normal and neoplastic tissues. In: Biochemistry of cancer, 2nd ed., p. 259–271. New York: Academic Press 1954.
Hackl, H.: Metabolische Studien humaner Endometrien in vitro. Manuskript.
Heckmann, U.: Zur Wirkung des Norhydroxyprogesteroncapronat auf das Adenocarcinoma corporis uteri in der Gewebekultur. Dtsch. med. Wschr.90, 2328 (1965).
Kaiser, R.: Die Wirkung von Gestagenen beim Korpuscarcinom. Arch. Gynäk.139, 195 (1959).
Kelley, R., andW. H. Baker: Progestional agents in the treatment of carcinoma of the endometrium. New Engl. J. Med.264, 216 (1961).
Kistner, R. W.: Treatment of carcinoma in situ of endometrium. Clin. Obstet. Gynec.5, 1166 (1962).
—: Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium. Cancer (Philad.)12, 1106 (1959).
Krahe, M.: Über den Stoffwechsel des Korpuscarcinoms und seine Beeinflussung durch Trenimon. Arch. Gynäk.196, 468 (1962).
Nordqvist, S. R. B.: Hormone effects on carcinoma of the human uterine body studied in organ culture. Acta obstet. gynec. scand.43, 296 (1964).
Olson, R. E.: Oxydation of C14-labelled carbohydrate intermediates in tumors and normal tissue. Cancer. Res.11, 571 (1951).
Racker, E.: Oxydative phosphorylation. Advanc. Enzymol.23, 340 (1961).
Sherman, A. I., andR. B. Woolf: An endocrine basis for endometrial carcinoma. Amer. J. Obstet. Gynec.77, 233 (1959).
Varga, A., andE. Henriksen: Clinical and histopatologic evaluation of the effect of 17-α-hydroxyprogesteron-17-n-caproate on endometrial carcinoma. Obstet. and Gynec.18, 658 (1961).
——: Histologic observations on the effect of 17-α-hydroxyprogesterone-17-n-caproate on endometrial carcinoma. Obstet and Gynec.26, 656 (1965).
Wade, R., andH. W. Jones: Effect of progesteron on oxydative phosphorylation. J. biol. Chem.220, 553 (1956).
Warburg, O.: Krebsforschung. Naturwissenschaften41, 485 (1954).
—,K. Posener u.E. Negelein: Über den Stoffwechsel der Carcinomzelle. Biochem. Z.152, 309 (1924).
Weinhouse, S.: Studies on the fate of isotopically labelled metabolites in the oxydative metabolism of tumors. Cancer Res.11, 585 (1951).
—: Oxydative metabolism of neoplastic tissue. Advanc. Cancer Res.3, 269 (1955).
Yardly, H. J.: A simplified scintillation-counting technique for assaying C14O2 in a Warburg flask. Nature (Lond.)204, 281 (1964).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hackl, H. In vitro-Stoffwechselstudien des Carcinoma corporis uteri. Arch. Gynak. 203, 464–473 (1966). https://doi.org/10.1007/BF00668615
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00668615